Coronavirus Treatment
Does Stem Cell Therapy in India has the Potential to Cure Covid-19 Disease?

Does Stem Cell Therapy in India has the Potential to Cure Covid-19 Disease?

We at Stem cell therapy India can fully understand this concern of yours after Hyderabad varsity startup developed stem cell-based treatment for Covid-19 using Mesenchymal Stem cells.

Though this development gives a ray of hope to millions of families in India whose patients are on their deathbed due to Covid-19 infection yet would not be helpful at all to these families because this stem cell therapy is in its trial phase in India and all over the world and no set of regulations have been issued by the government to use this Stem cell therapy in India.

Several studies done in the recent past by the scientist all over the world have indicated that there is a possibility that

Mesenchymal Stem Cell-Based Therapy for COVID-19 has the potential to cure Covid 19 disease.

Recently, A review, conducted by a group of Indian researchers, of the clinical data of patients in India and 5 other sources of literature, available till 10th August 2020, also confirmed its potential.

Here is an abstract of their report so let’s understand what their report said.

SARS-CoV-2, which mostly affects the lungs and respiratory tract, is believed to be caused by immune system dysregulation, which results in a massive cytokine imbalance.

However, no standard treatment for the disease has been established to date. On the other hand, preventing acute respiratory tract infection as a result of COVID-19, which is the most dangerous process with the highest mortality rate, becomes critical.

As a result, they pooled the data on the use of stem cells in SARS-CoV-2, SARS-CoV, MERS-CoV, and ARDS for their systematic analysis.

MSCs have the potential to resolve the clinical challenges that SARS-CoV-2 infected patients are currently facing, especially those who are severely ill and are not responding to traditional therapies.

Despite the encouraging clinical evidence, it would be too early in COVID-19 to estimate MSCs’ therapeutic potential. As a result, further research in a wider group of patients is needed to confirm their potential efficacy.

Leave a Reply

Your email address will not be published. Required fields are marked *